✦ LIBER ✦

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

✍ Scribed by Rubinson, Douglas A.; Hochster, Howard S.; Ryan, David P.; Wolpin, Brian M.; McCleary, Nadine Jackson; Abrams, Thomas A.; Chan, Jennifer A.; Iqbal, Syma; Lenz, Heinz J.; Lim, Dean; Rose, Jeffrey; Bekaii-Saab, Tanios; Chen, Helen X.; Fuchs, Charles S.; Ng, Kimmie

Book ID: 121558175
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 313 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9956-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of docetaxel plus oxaliplatin (D

Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study

✍ Richards, Donald; Kocs, Darren M.; Spira, Alexander I.; David McCollum, A.; Diab 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 395 KB

3055 POSTER Cetuximab plus irinotecan in

3055 POSTER Cetuximab plus irinotecan in patients (pts) with metastatic colorectal cancer (mCRC) progressing on or after prior irinotecan therapy: final results of the LABEL study

✍ C. de Cerqueira Mathias; F. Perazzo; S. Simon; L. Fein; J. Hidalgo; A.M. Murad; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

3046 POSTER A randomized, open-label pha

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Cetuximab in combination with irinotecan

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

✍ Jean-Luc Raoul; Jean-Luc Van Laethem; Marc Peeters; Catherine Brezault; Fares Hu 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 890 KB

6078 Cetuximab plus FOLFIRI in 1st-line

6078 Cetuximab plus FOLFIRI in 1st-line treatment of metastatic colorectal cancer: Quality of life (QoL) analysis of patients (pts) with KRAS wild-type (wt) tumours in the CRYSTAL trial

✍ Lang, I.; Köhne, C.H.; Folprecht, G.; Nowacki, M.P.; Cascinu, S.; Shchepotin, I. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB